Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan

Aim Single‐arm, open‐label, phase 3 study to evaluate the efficacy and safety of ferric derisomaltose (FDI) for iron deficiency anemia (IDA) in Japanese women with postpartum hemorrhage (PPH). Methods Postpartum women aged 20–39 years with serum ferritin

Saved in:
Bibliographic Details
Published in:The journal of obstetrics and gynaecology research 2023-03, Vol.49 (3), p.946-955
Main Authors: Sugimura, Motoi, Ohtani, Yasuyoshi, Tamai, Soichiro, Kishimoto, Umi, Ito, Naoki
Format: Article
Language:English
Subjects:
Adult
Anemia
Anemia, Iron-Deficiency - drug therapy
Depression, Postpartum
Female
Ferric Compounds
ferric derisomaltose
Ferritin
Ferritins - therapeutic use
Hemoglobin
Hemoglobins - analysis
Hemoglobins - therapeutic use
Hemorrhage
Humans
Infant, Newborn
intravenous iron preparation
Iron
Iron deficiency
iron deficiency anemia
Japan
Maltose
maternal milk
Neonates
Nutrient deficiency
Patients
Postpartum
Postpartum depression
Postpartum Hemorrhage
Pregnancy
Safety
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim Single‐arm, open‐label, phase 3 study to evaluate the efficacy and safety of ferric derisomaltose (FDI) for iron deficiency anemia (IDA) in Japanese women with postpartum hemorrhage (PPH). Methods Postpartum women aged 20–39 years with serum ferritin
ISSN:1341-8076
1447-0756
DOI:10.1111/jog.15546